n(6)-carboxymethyllysine has been researched along with Chronic Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballerin, L; Boschetto, P; Campo, I; Casimirri, E; Ceconi, C; Fabbri, LM; Fucili, A; Gorrini, M; Luisetti, M; Papi, A; Potena, A; Stendardo, M; Tinelli, C | 1 |
| Cai, W; Chen, X; Goodman, S; Pyzik, R; Ramdas, M; Striker, GE; Uribarri, J; Vlassara, H; Zhu, L | 1 |
| de la Maza, MP; del Castillo, MD; Filip, R; Garay-Sevilla, ME; Gugliucci, A; Luevano-Contreras, C; Macías-Cervantes, MH; Markowicz Bastos, DH; Medrano, A; Menini, T; Portero-Otin, M; Rojas, A; Sampaio, GR; Uribarri, J; Wrobel, K | 1 |
| Bandinelli, S; Ferrucci, L; Fink, JC; Guralnik, JM; Semba, RD; Sun, K | 1 |
| Ferrucci, L; Fink, JC; Semba, RD; Sun, K; Windham, BG | 1 |
| Baynes, JW | 1 |
| Hwang, JS; Shin, CH; Yang, SW | 1 |
| Gressner, AM; Kiefer, P; Lahme, B; Manns, MP; Tacke, F; Trautwein, C; Weiss, C; Yagmur, E | 1 |
1 review(s) available for n(6)-carboxymethyllysine and Chronic Disease
| Article | Year |
|---|---|
Dietary advanced glycation end products and their role in health and disease.
Topics: Agriculture; Chronic Disease; Cooking; Diet; Exercise; Food; Food Handling; Glycation End Products, Advanced; Health Status; Hot Temperature; Humans; Inflammation; Lysine; Mexico; Neurodegenerative Diseases; Oxidative Stress; Receptor for Advanced Glycation End Products; Solubility | 2015 |
1 trial(s) available for n(6)-carboxymethyllysine and Chronic Disease
| Article | Year |
|---|---|
Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases.
Topics: Aged; Biomarkers; Cell Line; Chronic Disease; Cooking; Feeding Behavior; Female; Gene Expression; Gene Silencing; Glycation End Products, Advanced; Humans; Life Style; Lysine; Male; Middle Aged; Oxidative Stress; PPAR gamma; Sirtuin 1 | 2014 |
6 other study(ies) available for n(6)-carboxymethyllysine and Chronic Disease
| Article | Year |
|---|---|
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
Topics: Aged; Biomarkers; Case-Control Studies; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Heart Failure; Humans; Lysine; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pulmonary Disease, Chronic Obstructive | 2013 |
Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults.
Topics: Aged; Aged, 80 and over; Chronic Disease; Cross-Sectional Studies; Educational Status; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Kidney Diseases; Kidney Function Tests; Logistic Models; Longitudinal Studies; Lysine; Male; Mental Status Schedule; Odds Ratio; Sex Characteristics; Smoking | 2009 |
Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.
Topics: Adult; Aged; Aged, 80 and over; Aging; Baltimore; Chronic Disease; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Kidney Diseases; Linear Models; Longitudinal Studies; Lysine; Male; Middle Aged; Racial Groups; Smoking | 2010 |
The clinical chemome: a tool for the diagnosis and management of chronic disease.
Topics: Biomarkers; Chromatography, Liquid; Chronic Disease; Glycation End Products, Advanced; Humans; Lipid Metabolism; Lipids; Lysine; Mass Spectrometry; Oxidation-Reduction; Renal Dialysis; Renal Insufficiency | 2004 |
Clinical implications of N epsilon-(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes.
Topics: Adolescent; Biomarkers; Case-Control Studies; Child; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Linear Models; Lysine; Male | 2005 |
Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis.
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Glycation End Products, Advanced; Humans; Hyaluronic Acid; Liver Cirrhosis; Lysine; Male; Middle Aged | 2006 |